Sunday, June 1, 2014

Merck presents early findings from Phase 1b study for pembrolizumab

See the rest of the story here.



Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corporate executives informed on what's moving stocks. Sign up for a free trial at theflyonthewall.com to see what Wall Street is buzzing about.

by via theflyonthewall.com

No comments:

Post a Comment